-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Eton Pharmaceuticals, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q3 2024.
- Eton Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.38M, a 0.17% decline year-over-year.
- Eton Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $3.17M, a 0.89% increase from 2023.
- Eton Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.14M, a 25.6% decline from 2022.
- Eton Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.22M, a 24.8% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)